2. Pharmaceuticals reported net income for FY2020 of $5.9 million on total revenues of $45 million. Depreciation expense totaled $925,000. (10 points) a) What were total expenses for FY2020? b) What were total cash expenses for FY2020? Assume that depreciation is a non-cash expense. c) What Pharmaceuticals estimated cash flow for FY2020? 2. Pharmaceuticals reported net income for FY2020 of $5.9 million on total revenues of $45 million. Depreciation expense totaled $925,000. (10 points) a) What were total expenses for FY2020? b) What were total cash expenses for FY2020? Assume that depreciation is a non-cash expense. c) What Pharmaceuticals estimated cash flow for FY2020